Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 114

1.

Acute and chronic mu opioids differentially regulate thrombospondins 1 and 2 isoforms in astrocytes.

Phamduong E, Rathore MK, Crews NR, D'Angelo AS, Leinweber AL, Kappera P, Krenning TM, Rendell VR, Belcheva MM, Coscia CJ.

ACS Chem Neurosci. 2014 Feb 19;5(2):106-14. doi: 10.1021/cn400172n. Epub 2013 Dec 5.

2.

Morphine modulation of thrombospondin levels in astrocytes and its implications for neurite outgrowth and synapse formation.

Ikeda H, Miyatake M, Koshikawa N, Ochiai K, Yamada K, Kiss A, Donlin MJ, Panneton WM, Churchill JD, Green M, Siddiqui AM, Leinweber AL, Crews NR, Ezerskiy LA, Rendell VR, Belcheva MM, Coscia CJ.

J Biol Chem. 2010 Dec 3;285(49):38415-27. doi: 10.1074/jbc.M110.109827. Epub 2010 Oct 2.

3.

Mu and kappa opioids modulate mouse embryonic stem cell-derived neural progenitor differentiation via MAP kinases.

Hahn JW, Jagwani S, Kim E, Rendell VR, He J, Ezerskiy LA, Wesselschmidt R, Coscia CJ, Belcheva MM.

J Neurochem. 2010 Mar;112(6):1431-41. doi: 10.1111/j.1471-4159.2009.06479.x. Epub 2009 Nov 6.

4.

Inhibition of EGF-induced ERK/MAP kinase-mediated astrocyte proliferation by mu opioids: integration of G protein and beta-arrestin 2-dependent pathways.

Miyatake M, Rubinstein TJ, McLennan GP, Belcheva MM, Coscia CJ.

J Neurochem. 2009 Jul;110(2):662-74. doi: 10.1111/j.1471-4159.2009.06156.x. Epub 2009 May 8.

5.

Kappa opioids promote the proliferation of astrocytes via Gbetagamma and beta-arrestin 2-dependent MAPK-mediated pathways.

McLennan GP, Kiss A, Miyatake M, Belcheva MM, Chambers KT, Pozek JJ, Mohabbat Y, Moyer RA, Bohn LM, Coscia CJ.

J Neurochem. 2008 Dec;107(6):1753-65. doi: 10.1111/j.1471-4159.2008.05745.x. Epub 2008 Nov 10.

6.

Mu- and kappa-opioids induce the differentiation of embryonic stem cells to neural progenitors.

Kim E, Clark AL, Kiss A, Hahn JW, Wesselschmidt R, Coscia CJ, Belcheva MM.

J Biol Chem. 2006 Nov 3;281(44):33749-60. Epub 2006 Sep 1.

7.

Increased opioid receptor binding and G protein coupling in the accumbens and ventral tegmental area of postnatal day 2 rats.

Hou Y, Belcheva MM, Clark AL, Zahm DS, Coscia CJ.

Neurosci Lett. 2006 Mar 13;395(3):244-8. Epub 2005 Nov 21.

8.

Mu and kappa opioid receptors activate ERK/MAPK via different protein kinase C isoforms and secondary messengers in astrocytes.

Belcheva MM, Clark AL, Haas PD, Serna JS, Hahn JW, Kiss A, Coscia CJ.

J Biol Chem. 2005 Jul 29;280(30):27662-9. Epub 2005 Jun 8.

9.

Differential effects of gestational buprenorphine, naloxone, and methadone on mesolimbic mu opioid and ORL1 receptor G protein coupling.

Hou Y, Tan Y, Belcheva MM, Clark AL, Zahm DS, Coscia CJ.

Brain Res Dev Brain Res. 2004 Jul 19;151(1-2):149-57.

PMID:
15246701
10.
11.
12.

Chronic morphine-induced changes in mu-opioid receptors and G proteins of different subcellular loci in rat brain.

Fábián G, Bozó B, Szikszay M, Horváth G, Coscia CJ, Szücs M.

J Pharmacol Exp Ther. 2002 Aug;302(2):774-80.

PMID:
12130743
13.

Diversity of G protein-coupled receptor signaling pathways to ERK/MAP kinase.

Belcheva MM, Coscia CJ.

Neurosignals. 2002 Jan-Feb;11(1):34-44. Review.

14.

mu-Opioid receptor-mediated ERK activation involves calmodulin-dependent epidermal growth factor receptor transactivation.

Belcheva MM, Szùcs M, Wang D, Sadee W, Coscia CJ.

J Biol Chem. 2001 Sep 7;276(36):33847-53. Epub 2001 Jul 16.

15.
18.

Kappa-opioid receptor binding varies inversely with tumor grade in human gliomas.

Pan EC, Bohn LM, Belcheva MM, Thomas GE, Manepalli AN, Mamone JY, Johnson FE, Coscia CJ.

Cancer. 1998 Dec 15;83(12):2561-6.

PMID:
9874464
20.

Brain opioid receptor adaptation and expression after prenatal exposure to buprenorphine.

Belcheva MM, Bohn LM, Ho MT, Johnson FE, Yanai J, Barron S, Coscia CJ.

Brain Res Dev Brain Res. 1998 Nov 1;111(1):35-42.

PMID:
9804882
21.

Evidence for kappa- and mu-opioid receptor expression in C6 glioma cells.

Bohn LM, Belcheva MM, Coscia CJ.

J Neurochem. 1998 May;70(5):1819-25.

22.

Opioid modulation of extracellular signal-regulated protein kinase activity is ras-dependent and involves Gbetagamma subunits.

Belcheva MM, Vogel Z, Ignatova E, Avidor-Reiss T, Zippel R, Levy R, Young EC, Barg J, Coscia CJ.

J Neurochem. 1998 Feb;70(2):635-45.

23.
24.

Opioid regulation of AP-1 DNA-binding activity in NG108-15 cells under conditions of opioid-receptor adaptation.

Tencheva ZS, Belcheva MM, Velichkova AA, Lissichkova EG, Coscia CJ.

Brain Res Mol Brain Res. 1997 Aug;48(1):156-8.

PMID:
9379837
25.

Elicitation of dihydrobenzophenanthridine oxidase in Sanguinaria canadensis cell cultures.

Ignatov A, Clark WG, Cline SD, Psenak M, Krueger J, Coscia CJ.

Phytochemistry. 1996 Dec;43(6):1141-4.

PMID:
8987906
27.

Buprenorphine differentially alters opioid receptor adaptation in rat brain regions.

Belcheva MM, Ho MT, Ignatova EG, Jefcoat LB, Barg J, Vogel Z, McHale RJ, Johnson FE, Coscia CJ.

J Pharmacol Exp Ther. 1996 Jun;277(3):1322-7.

28.

Dynorphins modulate DNA synthesis in fetal brain cell aggregates.

Gorodinsky A, Barg J, Belcheva MM, Levy R, McHale RJ, Vogel Z, Coscia CJ.

J Neurochem. 1995 Oct;65(4):1481-6.

29.

Modulation of opioid binding associated with nuclear matrix and nuclear membranes of NG108-15 cells.

Belcheva MM, Gucker S, Chuang DM, Clark WG, Jefcoat LB, McHale RJ, Toth G, Borsodi A, Coscia CJ.

J Pharmacol Exp Ther. 1995 Sep;274(3):1513-23.

PMID:
7562528
30.

Opioids inhibit endothelin-mediated DNA synthesis, phosphoinositide turnover, and Ca2+ mobilization in rat C6 glioma cells.

Barg J, Belcheva MM, Zimlichman R, Levy R, Saya D, McHale RJ, Johnson FE, Coscia CJ, Vogel Z.

J Neurosci. 1994 Oct;14(10):5858-64.

31.

Transient down-regulation of neonatal rat brain mu-opioid receptors upon in utero exposure to buprenorphine.

Belcheva MM, Dawn S, Barg J, McHale RJ, Ho MT, Ignatova E, Coscia CJ.

Brain Res Dev Brain Res. 1994 Jul 15;80(1-2):158-62.

PMID:
7955341
32.
33.

Naltrexone induces down- and upregulation of delta opioid receptors in rat brain regions.

Belcheva MM, Barg J, Mchale R, Coscia CJ.

Brain Res Bull. 1994;35(1):69-72.

PMID:
7953760
34.

Opioid receptor density changes in Alzheimer amygdala and putamen.

Barg J, Belcheva M, Rowinski J, Ho A, Burke WJ, Chung HD, Schmidt CA, Coscia CJ.

Brain Res. 1993 Dec 31;632(1-2):209-15.

PMID:
8149229
36.

Differential down- and up-regulation of rat brain opioid receptor types and subtypes by buprenorphine.

Belcheva MM, Barg J, McHale RJ, Dawn S, Ho MT, Ignatova E, Coscia CJ.

Mol Pharmacol. 1993 Jul;44(1):173-9.

38.
39.

Purification and characterization of dihydrobenzophenanthridine oxidase from elicited Sanguinaria canadensis cell cultures.

Arakawa H, Clark WG, Psenak M, Coscia CJ.

Arch Biochem Biophys. 1992 Nov 15;299(1):1-7.

PMID:
1444440
40.

Antagonist-induced transient down-regulation of delta-opioid receptors in NG108-15 cells.

Belcheva MM, Barg J, Gloeckner C, Gao XM, Chuang DM, Coscia CJ.

Mol Pharmacol. 1992 Sep;42(3):445-52.

PMID:
1328845
41.
42.

Differential development of beta-endorphin and mu opioid binding sites in mouse brain.

Barg J, Rius RA, Bem WT, Belcheva MM, Loh YP, Coscia CJ.

Brain Res Dev Brain Res. 1992 Mar 20;66(1):71-6.

PMID:
1318173
44.

Overexpression of sigma receptors in nonneural human tumors.

Bem WT, Thomas GE, Mamone JY, Homan SM, Levy BK, Johnson FE, Coscia CJ.

Cancer Res. 1991 Dec 15;51(24):6558-62.

45.

Distribution and metabolism of doxorubicin in rats undergoing testicular circulatory isolation.

Arakawa H, Mueller KJ, Doubek WG, Stern JA, La Regina MC, Tolman KC, Coscia CJ, Johnson FE.

Am J Surg. 1991 Dec;162(6):572-5.

PMID:
1670227
46.

Age-dependent changes in the subcellular distribution of rat brain mu-opioid receptors and GTP binding regulatory proteins.

Bem WT, Yeung SJ, Belcheva M, Barg J, Coscia CJ.

J Neurochem. 1991 Nov;57(5):1470-7.

PMID:
1655974
47.

Up-regulation of delta opioid receptors in neuroblastoma hybrid cells: evidence for differences in the mechanisms of action of sodium butyrate and naltrexone.

Belcheva MM, Barg J, McHale RJ, Gao XM, Chuang DM, Coscia CJ.

J Pharmacol Exp Ther. 1991 Oct;259(1):302-9.

PMID:
1656025
48.

Desipramine modulation of sigma and opioid peptide receptor expression in glial cells.

Barg J, Belcheva MM, Bem WT, Lambourne B, McLachlan JA, Tolman KC, Johnson FE, Coscia CJ.

Peptides. 1991 Jul-Aug;12(4):845-9.

PMID:
1664948
49.

A monoclonal anti-idiotypic antibody to mu and delta opioid receptors.

Coscia CJ, Szücs M, Barg J, Belcheva MM, Bem WT, Khoobehi K, Donnigan TA, Juszczak R, McHale RJ, Hanley MR, et al.

Brain Res Mol Brain Res. 1991 Mar;9(4):299-306.

PMID:
1645433
50.

The prenatal development profile of expression of opioid peptides and receptors in the mouse brain.

Rius RA, Barg J, Bem WT, Coscia CJ, Loh YP.

Brain Res Dev Brain Res. 1991 Feb 22;58(2):237-41.

Supplemental Content

Loading ...
Support Center